Significant Neurological Study for Lifestyle Related Diseases Worldwide From Now by Bando, Hiroshi
 
Manuscript no: JHCR-1-50 Volume: 1      Issue: 2       50 




             Journal of Health Care and Research 
 
  
                                                                                                                                      DOI: https://doi.org/10.36502/2020/hcr.6161 




1Medical Research/Tokushima University, Tokushima, Japan 
2Japan Low Carbohydrate Diet Promotion Association (JLCDPA), Kyoto, Japan 
 
Corresponding Author: Hiroshi BANDO, MD. PhD, FACP 
Address: Medical Research/Tokushima University, Nakashowa 1-61, Tokushima 770-0943, Japan; Tel: +81-90-3187-
2485; Fax: +81-88-603-1030; E-mail: pianomed@bronze.ocn.ne.jp 
Received date: 14 March 2020; Accepted date: 20 April 2020; Published date: 06 May 2020 
 
Citation: Bando H. Significant Neurological Study for Lifestyle Related Diseases Worldwide From Now. J Health 
Care and Research. 2020 May 6;1(2):50-54.  
 
Copyright © 2020 Bando H. This is an open-access article distributed under the Creative Commons Attribution 
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original 
work is properly cited. 
 
Keywords 
    European Society of Cardiology (ESC), European Society of Hypertension (ESH), ESC/ESH Guidelines for 
Hypertension, American Diabetes Association (ADA), Action to Control Cardiovascular Risk in Diabetes 
(ACCORD), Orthostatic Hypotension (OH) 
    An overview of modern medical society shows that 
various diseases of metabolic syndrome are 
increasing in both developed and developing 
countries [1]. Among them, hypertension and 
diabetes are the most frequent diseases which require 
continuous treatment for years. They are lifestyle-
related diseases and need the usual adequate habitual 
style for each person. 
 
    We can consider medical matters from the 
neurological point of view. A variety of nerve control 
and mental stress are involved in our daily lives. For 
example, blood pressure may increase in 
hypertension, and blood glucose value may increase 
in diabetes. In contrast, blood pressure may rapidly 
decrease in the diabetic patient with orthostatic 
hypotension (OH) due to diabetic neuropathy, when 
he changes his postures from lying to sitting, and 
from sitting to standing [2]. 
 
    In other words, various factors of the nervous, 
psychological, and psychiatric systems can affect 
hypertension and diabetes. Furthermore, they can also 
affect the diet from the stress, probably leading to 
obesity, dyslipidemia, hyperuricemia, gout, 
cerebrovascular accident (CVA), and coronary artery 
disease (CAD). Recent research shows that neural cell 
adhesion molecule-1 (NCAM-1) was significantly 
associated with an increased risk of CAD [3].  
 
    As for hypertension, remarkable progress has found 
in understanding the pathophysiology, epidemiology, 
and treatment. There is a wealth of evidence that 
lower control of blood pressure can substantially 
decrease morbidity, mortality, and other complications 
[4,5]. To achieve this goal, various effective and 
proven strategies of medication and a well-tolerated 
lifestyle have been necessary. However, the control of 
blood pressure has not been satisfactory in the world. 
By controlling blood pressure in an adequate range for 
patients with hypertension, CVA, and CAD can be 
preventable to some extent [6,7]. 
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    Recently, the European Society of Cardiology (ESC) 
and the European Society of Hypertension (ESH) have 
both published guidelines for hypertension in Europe 
[8,9]. Furthermore, practice guidelines for them were 
also published [10,11]. 2018 ESC/ESH guideline for 
the management of arterial hypertension has 89 
pages and 629 references [8,9], which seems to be 
satisfactory quality. From the neurological aspect, it 
includes white-coat hypertension, the brain in 
hypertension, cerebrovascular disease/cognition, and 
cognitive dysfunction/dementia.  
 
    Regarding the therapy for hypertension, 
antihypertensive agents should not be given from the 
beginning. Before medicine, non-drug therapy has 
been important, which is correcting or adjusting 
lifestyle. In addition to hypertensive patients, many 
people are in the preclinical stage for hypertensive 
tendencies. Such subjects are recommended to 
prevent hypertension by adjusting lifestyle in an 
appropriate way [12]. 
 
    There are several methods of non-drug therapy for 
adjusting lifestyle [8]. They include i) dietary sodium 
restriction [13], ii) moderation of alcohol 
consumption [14], iii) other dietary changes [15], iv) 
weight reduction [16], v) regular physical activity [17] 
and vi) smoking cessation [18].  
 
    As for clinical research for hypertension, authors 
and colleagues have reported the efficacy of adjusting 
the lifestyle [19]. Among thousands of hypertensive 
patients, the percentage of subjects who can 
discontinued antihypertensive agents was 
approximately 4.6% - 6.1% for several years. We 
have picked up 50 cases including 25 males and 25 
females and examined the detail of them. The results 
were that i) family history of hypertension was 
positive for 66% in women, ii) smoking ratio was 
76% in men, iii) alcohol consumption was 76% in 
men, iv) dyslipidemia was 42%, v) T2DM was 12%. It 
seems that 12% would be lower than the usual ratio 
because there is a higher prevalence of diabetes 
associated with hypertension. 
 
    One of the reasons would be the presence of 
macroangiopathy and microangiopathy from diabetic 
complications. Then, the existence of the impaired 
function of the blood vessel in the whole body may be 
involved. The improvement of blood pressure control 
would not be easy, because of already impaired 
vascular function. Six diabetic cases out of 50 subjects 
(12%) showed a weight reduction of 2.8 kg on average 
due to lifestyle adjustment [19]. Consequently, diabetic 
improvement seemed to be also beneficial to the 
hypertensive situation.  
 
    Diabetic patients have been at higher risk for 
kidney and cardiovascular diseases. They can lower 
the complication with lower blood pressure 
maintenance by adequate treatment [20]. American 
Diabetes Association (ADA) had proposed the guideline 
for high blood pressure in its standards of medical 
care in diabetes [21]. For patients with both diabetes 
and hypertension, a more detailed response has been 
required and recommended methods have been 
reported [20].  
 
    Concerning the blood pressure control in diabetic 
patients, both the blood flow in the cardiovascular 
system and regulation by the instantaneous nervous 
system has been involved in the various 
pathophysiological condition. For diabetic neuropathy, 
orthostatic hypotension (OH) is widely known as one 
of the autonomic nervous disorders.  
 
    Let me introduce the actual diabetic case with OH, 
from many patients that the author treated for long 
years. A case is a 59-year-old man associated with 
severe diabetic complications including 
microangiopathy and macroangiopathy. In the supine 
position on the bed, the blood pressure is 164/96. 
After changing the posture to the sitting position on 
the bed, it dropped to 126/78 at once. Successively, 
just after he changed standing up, blood pressure has 
fallen rapidly to 98/50. Furthermore, immediately 
after walking 2 or 3 steps, he felt blackout and fell on 
the floor. This episode can be involved in 
arteriosclerosis, hypertension, diabetes, neuropathy, 
OH, impaired blood pressure control system, and so 
on. These multiple factors may influence each other in 
the aggravating cycle.  
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    Formerly, Action to Control Cardiovascular Risk in 
Diabetes (ACCORD) group studied intensive blood 
pressure (BP) control in type 2 diabetes mellitus 
(T2DM) [22]. BP changes were checked after standing 
for 3 times in 3 minutes in more than 4000 T2DM 
patients. As a result, 20% of them showed OH. The 
definition of OH showed that orthostatic decline in 
systolic BP ≥20 mm Hg or diastolic BP ≥10 mm Hg, 
occurred at least 1 time [23]. Consecutively, further 
study was conducted in 4268 subjects. As a result, the 
relationships of OH showed positive for dizziness, 
fractures, later mortality, and negative for falls or 
CVD events [2].  
 
    In summary, this article described the topics 
concerning the neural regulation for hypertension 
and diabetes. For the treatment of metabolic 
syndrome and lifestyle related diseases for long, 
psychological and psychiatric control would be also 
necessary. As a new trial, there is computer research 
on the Internet of things (IoT) concerning stress, 
diabetes, and hypertension [24]. It is expected that 
current content would become a useful reference and 
that this journal would develop providing significant 
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